We are certainly excited about our patented (U.S. Patent 9,037,268) technology and its potential. Given the magnitude of the medical problem, we want to help get the technology into the research pipeline as quickly as possible. Hence the no-fee license.
Hartford, Connecticut (PRWEB) July 22, 2015
Remarkable Technologies, Inc. has unveiled what it believes is a promising new treatment approach for Alzheimer’s Disease, an incurable disease that affects 5.3 million people in the U.S. and nearly 44 million worldwide.
Eric Knight, Founder and President of Remarkable Technologies, Inc., said, “We are certainly excited about our patented (U.S. Patent 9,037,268) technology and its potential. Given the magnitude of the medical problem, we want to help get the technology into the research pipeline as quickly as possible. Hence the no-fee license.”
Remarkable Technologies, Inc. is providing a no-fee, non-exclusive patent license for R&D to bona fide medical researchers, scientists, and organizations. Information is available on the company’s special Web site: http://www.AlzheimersTreatmentInvention.com.
Radio waves are the key to the technology
Recent studies exposed RF energy to mice that have been genetically modified to exhibit Alzheimer’s Disease. Mice and humans share 95% of their genes, providing an appropriate reference for comparative studies. A study by the University of South Florida concluded “… we believe that the current lack of an effective therapeutic against [Alzheimer’s Disease], in concert with this study’s surprising findings, justifies EMF [RF energy] exposure as a non-invasive, non-pharmacologic approach worthy of vigorous investigation.” (The study as published in the Journal of Alzheimer’s Disease is available at http://www.AlzheimersTreatmentInvention.com.)
Eric Knight, with expertise in RF systems, was inspired by the research studies to develop an RF-delivery system for treating humans. On May 19, 2015, the U.S. Patent and Trademark Office granted a patent (U.S. Patent 9,037,268) on his technology innovation. (Knight has assigned the patent rights to his company, Remarkable Technologies, Inc.)
Patent provides nearly unbounded research opportunities
The patent covers a wide range of frequencies and signal intensities; various signal-modulation modes and RF-treatment patterns; and manual and computer-controlled systems. The patent provides researchers with a broad tool set to discover optimum treatment protocols. The company’s tested technology implementations are compliant with pertinent FCC regulations.
Versatile configurations and deployments
According to Knight, “The versatile nature of our patented technology allows for a wide range of technology deployments. For instance, it can be deployed as a simple, wearable device -- such as a hat or cap. Or embedded in a pillow or mattress for treatment while sleeping. Or as part of a sophisticated, computer-controlled RF-delivery system -- akin to a CAT or MRI system.”
Knight concluded, “By allowing scientists and researchers to experiment with our patented technology at no cost, we hope to unleash the power of many brilliant minds in parallel. We need to put a halt to this terrible disease, right now.”
About Remarkable Technologies, Inc.
Remarkable Technologies, Inc. (http://www.RemarkableTechnologies.com) was founded in 1994 by inventor and entrepreneur, Eric Knight. His vision was to create a company that provides innovative products and services that enhance business and empower people -- and those remain the company’s guiding principles today.
Remarkable Technologies, Inc. is a privately held corporation headquartered in Farmington, Connecticut, U.S.A.